Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Journal of Clinical Medicine · 15.11.2023 · 12 (22) · 7100
DOI: 10.3390/jcm12227100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.11.2023. Verfasst von Goushi Matama und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Ashahi-Machi 67, Kurume …. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research (C) from the Ministry of Edu-cation, Science, Sports, Japan, Kakihara Science Technology Foundation, Grant-in-Aid for Scientific Research (C).
Abstract (Originalsprache)
Periostin was investigated as a biomarker for rheumatoid arthritis-associated interstitial lung disease (RA-ILD). This prospective study measured serum monomeric and total periostin, Klebs von den Lungen-6 (KL-6), surfactant protein D (SP-D), and lactate dehydrogenase (LDH) in 19 patients with RA-ILD, 20 RA without ILD, and 137 healthy controls (HC). All biomarkers were higher in RA-ILD than HC or RA without ILD. KL-6 accurately detected ILD in RA patients (area under curve [AUC] = 0.939) and moderately detected SP-D and monomeric and total periostin (AUC = 0.803, =0.767, =0.767, respectively). Monomeric and total periostin were negatively correlated with normal lung area and positively correlated with honeycombing, reticulation, fibrosis score, and the traction bronchiectasis grade but not inflammatory areas. Serum levels of SP-D, KL-6, and LDH did not correlate with the extent of those fibrotic areas on high-resolution CT. Serum monomeric and total periostin were higher in patients with RA-ILD with definite usual interstitial pneumonia pattern compared with other ILD patterns. Immunohistochemical analyses of biopsy or autopsy lung tissues from RA-ILD during the chronic phase and acute exacerbation showed that periostin was expressed in fibroblastic foci but not inflammatory or dense fibrosis lesions. Periostin is a potential biomarker for diagnosis, evaluating fibrosis, and deciding therapeutic strategies for patients with RA-ILD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Ashahi-Machi 67, Kurume 830-0011, Japan.
- Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, Jigyohama 1-8-1, Chuou-ku, Fukuoka 810-0065, Japan.
- Department of Radiology, Kurume University School of Medicine, Ashahi-Machi 67, Kurume 830-0011, Japan.
- Department of Radiology, Kansai Rosai Hospital, Inabasou 3-1-69, Amagasaki 660-0064, Japan.
- Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Sakamoto 1-7-1, Nagasaki 852-8501, Japan.
- Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, Idaigaoka 1-1, Hasama-Machi, Yufu 879-5593, Japan.
ORCID-Profile: Masaki Okamoto, Masaki Tominaga, Noriho Sakamoto, Kosaku Komiya, Masamichi Komatsu, Yasuo Shimizu, Koichiro Takahashi, Yoshiaki Zaizen, Hiroaki Ida, Kenji Izuhara
Förderung
- Grant-in-Aid for Scientific Research (C) from the Ministry of Edu-cation, Science, Sports, Japan
- Kakihara Science Technology Foundation
- Grant-in-Aid for Scientific Research (C)
- Division of Respirology, Rheumatology, and Neurology, Department of Internal Medicine, Kurume University School of Medicine
- Shino-Test Co., Ltd.
Zitieren
APA
Matama, G., Okamoto, M., Fujimoto, K., Johkoh, T., Tominaga, M., Mukae, H., Sakamoto, N., Komiya, K., Umeki, K., Komatsu, M., Shimizu, Y., Takahashi, K., Tokisawa, S., Zaizen, Y., Matsuo, N., Nouno, T., Kaieda, S., Ida, H., Izuhara, K., & Hoshino, T. (2023). Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Journal of Clinical Medicine, 12(22), 7100. https://doi.org/10.3390/jcm12227100
Vancouver
Matama G, Okamoto M, Fujimoto K, Johkoh T, Tominaga M, Mukae H, et al. Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Journal of Clinical Medicine. 2023;12(22):7100. doi:10.3390/jcm12227100
BibTeX
@article{Matama2023,
author = {Matama, Goushi and Okamoto, Masaki and Fujimoto, Kiminori and Johkoh, Takeshi and Tominaga, Masaki and Mukae, Hiroshi and Sakamoto, Noriho and Komiya, Kosaku and Umeki, Kenji and Komatsu, Masamichi and Shimizu, Yasuo and Takahashi, Koichiro and Tokisawa, Saeko and Zaizen, Yoshiaki and Matsuo, Norikazu and Nouno, Takashi and Kaieda, Shinjiro and Ida, Hiroaki and Izuhara, Kenji and Hoshino, Tomoaki},
title = {Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {22},
pages = {7100},
doi = {10.3390/jcm12227100}
}
EUVIMED